Article
Novel mutations and phenotypic effect of the splice site modulator IVS3-48C in nine Swedish families with erythropoietic protoporphyria.
Journal of human genetics - 1 Jan 2003
Wiman Asa, Floderus Ylva, Harper Pauline
Abstract excerpt
Erythropoietic protoporphyria (EPP) is an inherited disorder, caused by a partial deficiency of ferrochelatase (FECH), the last enzyme of the heme biosynthetic pathway. The deficiency results in accumulation of protoporphyrin, primarily in erythroid cells, and the major clinical feature is cutaneous photosensitivity. In addition, some patients may develop liver complications. Several EPP-coupled mutations have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
